Show Summary Details
Page of

Surgery for liver metastases 

Surgery for liver metastases
Surgery for liver metastases

Robert A. Adair

, Alastair L. Young

, and Giles J. Toogood

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 25 July 2021

Up to 20% of patients present with synchronous liver metastases and a further 40% will develop metachronous liver disease

5 year survival following hepatic resection now approaches 40%

Extra-hepatic disease is no longer considered an absolute contraindication to curative resection

Management is dependent upon a multidisciplinary team approach in specialist, high volume, centres.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.